These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1306202)

  • 1. The changing panorama of shunt complications. Twenty-five years' experience.
    Serlo W; Heikkinen E; Von Wendt L
    J Neurosurg Sci; 1992; 36(4):207-10. PubMed ID: 1306202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Hydrocephalus in Children: Anatomic Imaging Appearances of CSF Shunts and Their Complications.
    Khalatbari H; Parisi MT
    AJR Am J Roentgenol; 2021 Jan; 216(1):187-199. PubMed ID: 33112667
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation and surveillance imaging of children with myelomeningocele and shunted hydrocephalus: a follow-up study.
    Wetzel JS; Heaner DP; Gabel BC; Tubbs RS; Chern JJ
    J Neurosurg Pediatr; 2019 Feb; 23(2):153-158. PubMed ID: 30497223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Medos Hakim programmable valve in the treatment of pediatric hydrocephalus.
    Reinprecht A; Dietrich W; Bertalanffy A; Czech T
    Childs Nerv Syst; 1997; 13(11-12):588-93; discussion 593-4. PubMed ID: 9454974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with the use of a shunt with an adjustable valve in children with hydrocephalus.
    Zemack G; Bellner J; Siesjö P; Strömblad LG; Romner B
    J Neurosurg; 2003 Mar; 98(3):471-6. PubMed ID: 12650416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent/guardian knowledge regarding implanted shunt type, setting, and symptoms of malfunction/infection.
    Ackerman LL; Fulkerson DH; Jea A; Smith JL
    J Neurosurg Pediatr; 2018 Apr; 21(4):359-366. PubMed ID: 29328006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the risk of a shunt malfunction after elective intradural surgery?
    Venable GT; Green CS; Smalley ZS; Bedford EC; Modica JS; Klimo P
    J Neurosurg Pediatr; 2015 Dec; 16(6):642-7. PubMed ID: 26359674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The necessity of shunt series.
    Vassilyadi M; Tataryn ZL; Alkherayf F; Udjus K; Ventureyra EC
    J Neurosurg Pediatr; 2010 Nov; 6(5):468-73. PubMed ID: 21039171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting shunt failure in children: should the global shunt revision rate be a quality measure?
    Rossi NB; Khan NR; Jones TL; Lepard J; McAbee JH; Klimo P
    J Neurosurg Pediatr; 2016 Mar; 17(3):249-59. PubMed ID: 26544083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and outcome of shunted hydrocephalus.
    Pople IK; Quinn MW; Bayston R
    Z Kinderchir; 1990 Dec; 45 Suppl 1():29-31. PubMed ID: 2293533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shunt revisions in children--can they be avoided? Experiences from a population-based study.
    Enger PØ; Svendsen F; Sommerfelt K; Wester K
    Pediatr Neurosurg; 2005; 41(6):300-4. PubMed ID: 16293949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study.
    Riva-Cambrin J; Kestle JR; Holubkov R; Butler J; Kulkarni AV; Drake J; Whitehead WE; Wellons JC; Shannon CN; Tamber MS; Limbrick DD; Rozzelle C; Browd SR; Simon TD;
    J Neurosurg Pediatr; 2016 Apr; 17(4):382-90. PubMed ID: 26636251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants.
    Willis BK; Kumar CR; Wylen EL; Nanda A
    Pediatr Neurosurg; 2005; 41(4):178-85. PubMed ID: 16088252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the cerebrospinal fluid protein concentration increase the risk of shunt complications?
    Brydon HL; Hayward R; Harkness W; Bayston R
    Br J Neurosurg; 1996 Jun; 10(3):267-73. PubMed ID: 8799537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventriculoatrial or ventriculoperitoneal shunts in the treatment of hydrocephalus in children?
    Fernell E; von Wendt L; Serlo W; Heikkinen E; Andersson H
    Z Kinderchir; 1985 Dec; 40 Suppl 1():12-4. PubMed ID: 4090749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life.
    Paulsen AH; Lundar T; Lindegaard KF
    J Neurosurg Pediatr; 2015 Dec; 16(6):633-41. PubMed ID: 26359766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative cerebrospinal fluid wound leakage as a predictor of shunt infection: a prospective analysis of 205 cases. Clinical article.
    Jeelani NU; Kulkarni AV; Desilva P; Thompson DN; Hayward RD
    J Neurosurg Pediatr; 2009 Aug; 4(2):166-9. PubMed ID: 19645552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revision rate of pediatric ventriculoperitoneal shunts after 15 years.
    Stone JJ; Walker CT; Jacobson M; Phillips V; Silberstein HJ
    J Neurosurg Pediatr; 2013 Jan; 11(1):15-9. PubMed ID: 23101557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posthemorrhagic hydrocephalus and shunts: what are the predictors of multiple revision surgeries?
    Chittiboina P; Pasieka H; Sonig A; Bollam P; Notarianni C; Willis BK; Nanda A
    J Neurosurg Pediatr; 2013 Jan; 11(1):37-42. PubMed ID: 23101558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.